Benitec Biopharma Inc expected to post a loss of 20 cents a share - Earnings Preview

Benitec Biopharma

12/05/2023 13:51

* Benitec Biopharma Inc  BNTC.OQ   BNTC.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 15
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Benitec Biopharma
Inc is
for a loss of 20 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Benitec
Biopharma
Inc is $4​, above​ its last closing price of $0.23. ​​​

This summary was machine generated May 12 at 12:51 GMT.  All
figures in US dollars  unless otherwise stated